Clinical Trial Update: Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the safety and efficacy of lenalidomide for refractory cutaneous lupus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Cutaneous Lupus | Phase 4 | Status: COMPLETED